
Alkem Laboratories Limited has informed the Exchange regarding a press release dated February 28, 2024, titled "Closure of US FDA Inspection at Company's API manufacturing facility located at Mandva.".
Filed with NSE ·

Alkem Laboratories Limited has informed the Exchange regarding a press release dated February 28, 2024, titled "Closure of US FDA Inspection at Company's API manufacturing facility located at Mandva.".
6ix hasn’t read this filing yet.
Alkem Laboratories Ltd. on 6ix
Follow Alkem Laboratories into a list and get an email when it puts out news.
Follow Alkem Laboratories